Cargando…

Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients

We conducted this study to evaluate the diagnostic value of Inflammatory Factors (IFs) in the pathology of bladder cancer patients. The patients who were diagnosed with urothelial bladder carcinoma (bladder cancer) and underwent surgical treatment in our center from 2014 to 2019 were enrolled. The v...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xingxing, Cao, Yudong, Liu, Jia, Wang, Shuo, Yang, Yong, Du, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674661/
https://www.ncbi.nlm.nih.gov/pubmed/33251247
http://dx.doi.org/10.3389/fmolb.2020.575483
_version_ 1783611551845974016
author Tang, Xingxing
Cao, Yudong
Liu, Jia
Wang, Shuo
Yang, Yong
Du, Peng
author_facet Tang, Xingxing
Cao, Yudong
Liu, Jia
Wang, Shuo
Yang, Yong
Du, Peng
author_sort Tang, Xingxing
collection PubMed
description We conducted this study to evaluate the diagnostic value of Inflammatory Factors (IFs) in the pathology of bladder cancer patients. The patients who were diagnosed with urothelial bladder carcinoma (bladder cancer) and underwent surgical treatment in our center from 2014 to 2019 were enrolled. The values of Neutrophil to Lymphocyte Ratio (NLR), derived Neutrophil to Lymphocyte Ratio (dNLR), Platelet to Lymphocyte Ratio (PLR), Lymphocyte to Monocyte Ratio (LMR), Systemic Immune-inflammation Index (SII), and Prognostic Nutritional Index (PNI) were calculated by blood routine test results before operation. After obtaining the postoperative pathology of the patients, the Area Under Curve (AUC) of Receiver Operating Characteristic (ROC) curves was calculated to evaluate the diagnostic value of these IFs in pathology and their corresponding cut-off values. A total of 641 bladder cancer patients were enrolled. The median values of NLR, dNLR, PLR, LMR, SII, and PNI were 6.33, 4.09, 156.47, 2.66, 1114.29, and 51.45, respectively. Grouped patients according to the pathological grade, the NLR, dNLR, PLR, and SII of the high-grade group were significantly higher than those of the low-grade group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while the LMR and PNI were significantly lower than those of the low-grade group (P = 0.003 and P < 0.001). Divided patients into non-muscle invasion group (Tis + Ta + T1) and muscle invasion group (T2 + T3 + T4), in which NLR, dNLR, PLR, and SII in the muscle invasion group were significantly higher than those in the non-muscle invasion group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while LMR and PNI were significantly lower than those in the low-grade group (P = 0.012 and P < 0.001). ROC curves analyses showed that NLR, dNLR, PLR, LMR, SII, and PNI had predictive value for pathological grade (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively) and muscle invasion (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively). The results suggest the higher NLR, dNLR, PLR, SII, and lower LMR and PNI are associated with higher risk of high-grade and muscle invasive disease. However, this conclusion needs to be further clarified in the future.
format Online
Article
Text
id pubmed-7674661
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76746612020-11-27 Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients Tang, Xingxing Cao, Yudong Liu, Jia Wang, Shuo Yang, Yong Du, Peng Front Mol Biosci Molecular Biosciences We conducted this study to evaluate the diagnostic value of Inflammatory Factors (IFs) in the pathology of bladder cancer patients. The patients who were diagnosed with urothelial bladder carcinoma (bladder cancer) and underwent surgical treatment in our center from 2014 to 2019 were enrolled. The values of Neutrophil to Lymphocyte Ratio (NLR), derived Neutrophil to Lymphocyte Ratio (dNLR), Platelet to Lymphocyte Ratio (PLR), Lymphocyte to Monocyte Ratio (LMR), Systemic Immune-inflammation Index (SII), and Prognostic Nutritional Index (PNI) were calculated by blood routine test results before operation. After obtaining the postoperative pathology of the patients, the Area Under Curve (AUC) of Receiver Operating Characteristic (ROC) curves was calculated to evaluate the diagnostic value of these IFs in pathology and their corresponding cut-off values. A total of 641 bladder cancer patients were enrolled. The median values of NLR, dNLR, PLR, LMR, SII, and PNI were 6.33, 4.09, 156.47, 2.66, 1114.29, and 51.45, respectively. Grouped patients according to the pathological grade, the NLR, dNLR, PLR, and SII of the high-grade group were significantly higher than those of the low-grade group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while the LMR and PNI were significantly lower than those of the low-grade group (P = 0.003 and P < 0.001). Divided patients into non-muscle invasion group (Tis + Ta + T1) and muscle invasion group (T2 + T3 + T4), in which NLR, dNLR, PLR, and SII in the muscle invasion group were significantly higher than those in the non-muscle invasion group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while LMR and PNI were significantly lower than those in the low-grade group (P = 0.012 and P < 0.001). ROC curves analyses showed that NLR, dNLR, PLR, LMR, SII, and PNI had predictive value for pathological grade (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively) and muscle invasion (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively). The results suggest the higher NLR, dNLR, PLR, SII, and lower LMR and PNI are associated with higher risk of high-grade and muscle invasive disease. However, this conclusion needs to be further clarified in the future. Frontiers Media S.A. 2020-11-05 /pmc/articles/PMC7674661/ /pubmed/33251247 http://dx.doi.org/10.3389/fmolb.2020.575483 Text en Copyright © 2020 Tang, Cao, Liu, Wang, Yang and Du. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Tang, Xingxing
Cao, Yudong
Liu, Jia
Wang, Shuo
Yang, Yong
Du, Peng
Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients
title Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients
title_full Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients
title_fullStr Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients
title_full_unstemmed Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients
title_short Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients
title_sort diagnostic value of inflammatory factors in pathology of bladder cancer patients
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674661/
https://www.ncbi.nlm.nih.gov/pubmed/33251247
http://dx.doi.org/10.3389/fmolb.2020.575483
work_keys_str_mv AT tangxingxing diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients
AT caoyudong diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients
AT liujia diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients
AT wangshuo diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients
AT yangyong diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients
AT dupeng diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients